Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

Trodelvy Lengthens Time to Disease Progression in Metastatic Breast Cancer

September 7th 2022

Trodelvy bested chemotherapy for progression-free survival in patients with HR-positive, HER2-negative metastatic breast cancer.

I’m Not a ‘Cancer Warrior,’ But I Am a ‘Joy Warrior’

August 30th 2022

I’m giving cancer’s “battle language” an update and focusing my survivorship plan on emotional wellbeing and honesty.

Unraveling the Layers of Metastatic Breast Cancer

August 22nd 2022

The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.

Patient With Metastatic Breast Cancer Recalls Witness of Data Leading to Enhertu Approval in HER2-Low Disease

August 17th 2022

A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

FDA Grants Enhertu a Priority Review for Metastatic HER2-Low Breast Cancer

July 25th 2022

If approved, Enhertu may “redefine how we classify and treat metastatic breast cancer,” according to a representative from the drug’s manufacturer.

Patient Advocacy at ASCO 2022

July 22nd 2022

This year, I returned to the American Society of Clinical Oncology meeting, where I heard about the latest advancements in cancer care, as well as met with fellow patients and advocates.

Rejecting Breast Reconstruction, Accepting Myself and Going Fabulously Flat

July 21st 2022

After experiencing complications from breast reconstruction, I’ve decided to go “fabulously flat” and evict my implants.

My Oncologist Treated Me Like Family

July 18th 2022

At first, I was apprehensive about a male doctor treating my breast cancer, but I soon realized that he was treating me as he would his own family members — and that made me realize that I was in good hands.

Sometimes the Reality of Cancer Gets Lost in Translation

July 13th 2022

When a friend with metastatic breast cancer said that her cancer responded to treatment and she was excited to stop taking daily pills, I thought that something must have been miscommunicated to her.

I'm a 'Cancer Long-Hauler'

July 8th 2022

I typically don’t use cancer labels, such as “survivor” or “thriver,” but when I heard about COVID-19 “long-haulers,” the term resonated with me.

Educated Patient® Metastatic Breast Cancer Summit Outside of Treatment Panel: June 11, 2022

July 5th 2022

Watch Emily Huskey, Dr. Wendy Baer, Fabienne Ehivet and Lisa Weems answer questions about areas outside of treatment during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Genetic Testing Presentation: June 11, 2022

July 4th 2022

Watch Fabienne Ehivet, from Emory Saint Joseph’s Hospital, discuss genetic testing, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Psychosocial Issues Presentation: June 11, 2022

July 3rd 2022

Watch Dr. Wendy Baer, from Winship Cancer Institute at Emory University, discuss psychosocial issues, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Diet & Exercise Presentation: June 11, 2022

July 2nd 2022

Watch Emily Huskey, from the Winship Cancer Institute of Emory University, discuss diet and exercise, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Additional Care Panel: June 11, 2022

July 1st 2022

Watch Dr. Kimberly Curseen, Dr. Anna Bausum, Dr. Kevin Kalinsky and Alyncia Mason answer questions about additional care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Clinical Trials Presentation: June 11, 2022

June 30th 2022

Watch Dr. Kevin Kalinsky, from Winship Cancer Institute of Emory University, discuss joining clinical trials, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Thanks for the Mammaries: An Ode to My Prosthetic Breast

June 29th 2022

After seven years, my prosthetic breast, “Rightie,” sprung a leak and needed to be replaced.

Educated Patient® Metastatic Breast Cancer Summit Integrating Alternative Medicine Presentation: June 11, 2022

June 29th 2022

Watch Dr. Anna Bausum, Winship Cancer Institute at Emroy University, discuss alternative medicine, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Supportive Care Presentation: June 11, 2022

June 28th 2022

Watch Dr. Kimberly Curseen, from Winship Cancer Institute of Emory University, discuss supportive care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

New Resource ‘Empowers’ Patients With Breast Cancer That Has Spread to the Brain With Much Needed Information

June 27th 2022

Receiving a diagnosis of metastatic breast cancer that has spread to the brain can be a frightening time for patients, however a new resource may help guide them through the stressful journey.

Educated Patient® Metastatic Breast Cancer Summit Updates in Disease Management Panel: June 11, 2022

June 27th 2022

Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Metastatic Triple-Negative Presentation: June 11, 2022

June 26th 2022

Watch Dr. Keerthi Gogineni, from Emory University School of Medicine, discuss the management of triple-negative disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Estrogen Receptor-Positive Presentation: June 11, 2022

June 24th 2022

Watch Dr. Suchita Pakkala, from Emory University School of Medicine, discuss estrogen receptor-positive disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Patients With Metastatic Breast Cancer Should Be in the Driver's Seat for Their Treatment Planning

June 23rd 2022

In CURE®’s “Speaking Out” video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for brain metastases in breast cancer and how patients can take part in driving their care.

Two Angels of Oncology

June 18th 2022

I hope every patient and their family can feel the caring that two angels standing by a shoulder can bring.

My Experience With Medical Upselling

June 16th 2022

After surviving cancer, I knew what medical upselling looked like, and experienced it firsthand when a clinician tried to send me for more tests than I felt necessary.

After Receiving a Cancer Diagnosis, I Didn’t Think About Oral Health, Though I Should Have

June 10th 2022

Cancer and its treatments can affect oral health, though when I was diagnosed with breast cancer, the thought of seeing the dentist slipped my mind.

My Third and Fourth Cancer Opinions Gave Me a Second Chance at Life

June 8th 2022

Getting other medical opinions for my cancer diagnosis not only saved my life but also taught me self-care.

Enhertu Fulfills ‘Big Unmet Need’ for Patients with HER2-Low Metastatic Breast Cancer

June 7th 2022

The findings of the study show that Enhertu should be a new standard of care for patients with HER2-low metastatic breast cancer, according to an expert at Memorial Sloan Kettering Cancer Center.

Early Study Findings Show Novel Drug Elicits Promising Results in Metastatic Breast Cancers

June 6th 2022

At a follow-up of more than two years, treatment with a novel drug produced meaningful results in a group of patients with HER3-expressing metastatic breast cancer or metastatic triple-negative breast cancer.

NEXT PAGE
PREVIOUS PAGE